12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Lantern Pharma (NASDAQ:LTRN) shares rose 14.3% to $7.04 during Friday’s after-market session. The company’s market cap stands…
Top 4 Health Care Stocks You May Want To Dump In February
As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock increased by 55.3% to $5.08 during Thursday’s regular session. The market value of…
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results.
AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion.
AMD shares dipped 3.8% to $165.49 on Wednesday.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers SINTX Techs (NASDAQ:SINT) shares increased by 75.0% to $0.41 during Tuesday’s after-market session. The market value of…
Solid Biosciences Granted FDA Orphan Drug Designation For Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003; Patient Dosing Expected To Begin Mid-To-Late Q1 2024
– Patient dosing expected to begin mid-to-late Q1 2024 – CHARLESTOWN, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB), a life sciences company developing precision genetic medicines for
Insiders Buying Solid Biosciences And 2 Other Stocks
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers NexImmune (NASDAQ:NEXI) shares rose 97.5% to $14.95 during Tuesday’s regular session. The company’s market cap stands at…
Solid Biosciences Announces $109M Private Placement Selling $16.97M Shares to Fund Ongoing Pipeline Development Programs
Solid Biosciences Inc. (NASDAQ:SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has entered into a securities purchase agreement with a